InMed Pharmaceuticals Inc (INM)

[Aladdin80]

Going to have to agree w/Steve here. Although Almac brings some nice pedigree, it tells the investor nothing in regards to the pivoted pathway or pathways to be using Almac. As I've said time and time before it only confirms more delays. They've been working w/them for a few months which would indicate a hard pivot to Almac once pathway 1 hit the biological burden dead-end. So what's the time line now to complete biosynthesis? What is the impact to earlier projections to be commercializing by year end? What are the terms of the new partnership?

From my perspective they're absolutely still in an exploratory stage and no where near commercialization.